An inexpensive antidepressant drug has been found to reduce the risk of hospitalization in high-risk adults recently diagnosed with COVID-19 by over 30 percent, according to a study published in The Lancet Global Health. The study, titled, “Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised,…
Inexpensive Antidepressant Found to Reduce COVID-19 Hospitalizations by Over 30 Percent: Study
Certain Immunocompromised Americans Can Get Four COVID-19 Vaccine Doses: CDC
Some Americans can get four COVID-19 vaccine doses within less than a year, the Centers for Disease Control and Prevention (CDC) said this week. U.S. drug regulators and the CDC recently cleared booster doses of all three COVID-19 vaccines authorized for use in the country. The fourth dose would be for people who are either…
Merck Asks EU Regulator to Authorize Pill That Treats COVID-19
AMSTERDAM—The pharmaceutical company Merck says it has asked the European Medicines Agency to authorize its COVID-19 antiviral treatment, the first pill that has been shown to treat the disease. In a statement on Monday, Merck said the EU drug regulator had started an expedited licensing process for molnupiravir. If given the green light, it would…
NYC Rally Against Vaccine Mandate; ‘Kyrie Irving Is a Hero!’: Protesters Back Irving’s Stand Against Mandates
“You’re not a hero if you’ve got a multimillion-dollar deal from Nike. You’re a hero when you stand up against the majority for what’s right, and that’s exactly what Kyrie is doing,” said NYC Council candidate Mark Szuszkiewicz, who was among the hundreds who rallied on Oct. 24 in support of Brooklyn Nets basketballer Kyrie…
Dr. Gandhi: Fighting COVID-19 Without Ruining Lives; the At-Risk People Progressives Left Behind
Monica Gandhi is an infectious diseases and HIV doctor at the University of California–San Francisco. Her stance against COVID-19 restrictions that harm more than help vulnerable people—such as the poor, the homeless, and those being treated for HIV—has brought her into the social media spotlight. As medical director of San Francisco General Hospital’s HIV clinic,…
COVID-19 Antiviral Pill From Roche, Atea Fails to Help Patients With Mild or Moderate Symptoms
A pill developed by two drugmakers failed to help COVID-19 patients with mild or moderate symptoms, one of the companies announced Tuesday. Atea Pharmaceuticals and Roche tested their experimental treatment in a Phase 2 trial in outpatient settings, or non-hospitalized patients. The study failed to meet the primary endpoint, which was a reduction in the…
Doctors Can Prescribe Ivermectin, Hydroxychloroquine Off-Label for COVID-19: Nebraska AG
Nebraska Attorney General Doug Peterson issued a legal opinion saying that his office won’t seek disciplinary action against doctors who prescribe hydroxychloroquine or ivermectin as off-label medicines to treat or prevent COVID-19, as long as they are not engaging in any misconduct. The opinion (pdf), issued on Oct. 15, was in response to a request from…
Children Much More Likely to Have Asymptomatic Cases of COVID-19: Study
Children are much more likely to have cases of COVID-19 without showing symptoms than adults, according to a new study. Roughly half the children between 0 and 11 years old who tested positive for COVID-19 across households studied in New York City and some counties in Utah showed no symptoms, researchers found. Almost half the…
Merck Seeks Authorization From US Regulators for Antiviral COVID-19 Treatment
Merck and its partner on Monday announced they filed an emergency use authorization application with the U.S. Food and Drug Administration (FDA) for their oral antiviral medicine for the treatment of COVID-19. The pill is meant to combat cases of mild or moderate COVID-19. Merck said last week that an interim analysis of its phase…
Australian Medical Manufacturer Recalls Nearly 200,000 COVID-19 Tests in US Over ‘False Positive’ Results
Nearly 200,000 at-home COVID-19 tests in the United States have been recalled by Australian medical tech manufacturer Ellume after the company identified that they produced an incorrect positive result. Ellume was given an emergency authorization in December by the U.S. Food and Drug Administration (FDA) to supply the COVID-19 Home Test for non-prescription use by symptomatic and asymptomatic individuals aged 2…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`